Navigation Links
Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients
Date:2/28/2011

ase are forward-looking statements that reflect management's current views and expectations with respect to future events, including the expansion and commencement of clinical trials and the outcome and expenses of such trials.  These forward-looking statements are not a guarantee of future events and are subject to a number of risks and uncertainties, many of which are outside our control, which could cause actual events to differ materially from those expressed or implied by the statements.  These risks and uncertainties are based on a number of factors, including but not limited to receipt of adequate funding to expand and commence clinical trials; receipt of applicable regulatory approvals for clinical trials, the risks related to the ownership and enforceability of our licensed intellectual property necessary to conduct the clinical trials and the business risks disclosed in our SEC filings, especially the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010.  We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.Omni Bio Pharmaceutical, Inc.

Hayden IR  Edward C. Larkin, Chief Operating Officer

Brett Maas, Managing Partner(720) 488-4708

(646) 536-7331Email: brett@haydenir.com   - or -Cameron Donahue, Partner(651) 653-1854Email: cameron@haydenir.com
'/>"/>

SOURCE Omni Bio Pharmaceutical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
(Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... Amex: CXM ) today provided an update regarding ... assets in connection with a proposed asset purchase under Chapter ... 27, 2011, the completion of such an asset purchase is ... bankruptcy court.  In an effort to expedite the proposed transaction, ...
... The National Association of Boards of ... Americans about the serious dangers associated with medicines purchased ... on Internet drug outlets found that 96% of 8,000 ... compliance with United States pharmacy laws, fuel prescription drug ...
Cached Medicine Technology:Cardium Reports on Transdel Transaction 2Cardium Reports on Transdel Transaction 3Cardium Reports on Transdel Transaction 4NABP Issues Rogue Online Pharmacy Public Health Alert 2NABP Issues Rogue Online Pharmacy Public Health Alert 3NABP Issues Rogue Online Pharmacy Public Health Alert 4
(Date:9/22/2014)... Mississauga, Ontario (PRWEB) September 22, 2014 ... August 1st, 2014 at the PWN International Conference in ... Canadian release that was celebrated with a reception attended ... this reception Dawn shared insights she had gained while ... organizational side of the glass ceiling issue, and what ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Fancyflyingfox.com, the well-known ... collection of 2014 plus size wedding dresses . In ... offer for these fashionable plus size outfits. Each item in ... price, up to 65% off. , The company has ... of them are now available at extremely affordable prices. Its ...
(Date:9/21/2014)... September 22, 2014 CareSpan USA, Inc. ... entered into a joint services agreement with Avera eCARE, ... deploy the CareSpan Virtual Clinic in multiple states where ... plan to deploy their joint services in remote and ... where Avera eCARE is licensed. The two companies’ strategy ...
(Date:9/21/2014)... study of cancer patients who smoke, those using e-cigarettes ... and equally or less likely to have quit smoking ... Cancer , a peer-reviewed journal of the American Cancer ... of e-cigarettes for helping cancer patients give up smoking. ... cancer patients who smoke should be advised to quit. ...
(Date:9/21/2014)... of the leading online stores of real and synthetic hair ... human hair lace wigs inspired by 6 famous celebrities. It’s ... latest celebrity hairstyles are. , For people who ... to choose from: a style of yaki straight lace wig, ... ombre red lace wig. People can go to the product ...
Breaking Medicine News(10 mins):Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Discounted Plus Size Wedding Dresses Available At Fancyflyingfox.com 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2
... looking to benefit from the lucrative coaching market , ... Cincinnati (PRWEB) ... employee wellness market. Companies interested in exploiting this market opportunity face ... goal of controlling skyrocketing health insurance costs, a third of organizations already ...
... Space Shuttle delivered high-resolution video , ... Van Nuys, ... leader in high-quality lenses for industrial applications, has just announced that ... to play an important role in the recent servicing in orbit ...
... Metropolitan area physicians , ... Rye Brook, N.Y. (PRWEB) ... providers of specialized anatomic pathology services, today announced the opening of ... enhance services for Metropolitan area physicians. Licensed by the New York ...
... Federal And State Dollar Spent, 96 Cents Goes to Shovel ... Goes to Prevention and TreatmentWASHINGTON, May 28 ... at least $467.7 billion in 2005, according to Shoveling ... and Local Budgets, a new 287-page report released today ...
... Construction and Sleep Experts have been honored as ... Ethics Awards. Two area medical facilities, Texas Institute ... were among the nine finalists.The other 2009 finalists ... Aspire, Cadence McShane Construction Company and The Dwyer ...
... Texas; PHILADELPHIA The Lance Armstrong Foundation (LAF) ... to further develop and disseminate the LIVESTRONG Care ... service gives cancer survivors, their families and physicians ... care using up-to-date treatment information based on Institute ...
Cached Medicine News:Health News:Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it? 2Health News:Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it? 3Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 2Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 3Health News:CBLPath Opens Manhattan Facility 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 3Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 4Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 5Health News:Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards 2Health News:LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: